A Prospective, Observational Trial on the Diagnostic and Prognostic of LM
NCT02607605 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2017-10-26
Summary
The primary purpose of this study is to compare the positive rate between the cell-free DNA and cytological examination of cerebrospinal fluid in Advanced lung cancer with leptomeningeal metastases.
Conditions
- Lung Neoplasms
- Meningeal Carcinomatosis
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Principal Investigators
-
li-kun Chen, Doctor · Sun Yat-sen University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2019-12-31
- Completion
- 2020-08-31
Countries
- China
Study Locations
More Related Trials
-
Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer
NCT07107035 ·Status: NOT_YET_RECRUITING
-
Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer
NCT07034365 ·Status: NOT_YET_RECRUITING
-
Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients
NCT05721963 ·Status: UNKNOWN
-
Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
NCT06684418 ·Status: RECRUITING
-
An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
NCT03413956 ·Status: COMPLETED
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
NCT06718972 ·Status: RECRUITING
-
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer
NCT03679936 ·Status: UNKNOWN
-
Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival
NCT07100444 ·Status: COMPLETED
-
Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis
NCT06517979 ·Status: RECRUITING
-
The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients
NCT02505139 ·Status: COMPLETED
-
Genomic Study in Non-small Cell Lung Cancer Brain Metastasis
NCT04745715 ·Status: COMPLETED
-
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
NCT05425134 ·Status: UNKNOWN
-
CTC in Lung Caner Patients With Bone Metastases
NCT04568291 ·Status: UNKNOWN ·Phase: NA
-
A Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung Cancer
NCT06161935 ·Status: COMPLETED
-
A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer
NCT03429192 ·Status: COMPLETED
-
Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction
NCT03053804 ·Status: UNKNOWN ·Phase: NA
-
Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma
NCT03641105 ·Status: UNKNOWN
-
Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural Effusion
NCT04263688 ·Status: UNKNOWN
-
Comparison of Gene Mutations in Matched Samples in Advanced Nonsquamous NSCLC Using NGS
NCT02416726 ·Status: COMPLETED ·Phase: NA
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
Analysis of Brain Metastasis in Patients With Lung Cancer
NCT00071344 ·Status: COMPLETED
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS
NCT03465241 ·Status: COMPLETED
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED